β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project.
Michel, Martin C
β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project. [electronic resource] - Pharmacology & therapeutics Mar 2016 - 66-82 p. digital
Publication Type: Journal Article; Review
1879-016X
10.1016/j.pharmthera.2016.01.007 doi
Adrenergic beta-3 Receptor Agonists--pharmacology
Adrenergic beta-3 Receptor Antagonists--pharmacology
Animals
Antibodies--pharmacology
Drug Repositioning
Humans
Ligands
Receptors, Adrenergic, beta-3--genetics
Syndrome
Translational Research, Biomedical
Urinary Bladder--physiology
Urinary Bladder, Overactive--drug therapy
β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project. [electronic resource] - Pharmacology & therapeutics Mar 2016 - 66-82 p. digital
Publication Type: Journal Article; Review
1879-016X
10.1016/j.pharmthera.2016.01.007 doi
Adrenergic beta-3 Receptor Agonists--pharmacology
Adrenergic beta-3 Receptor Antagonists--pharmacology
Animals
Antibodies--pharmacology
Drug Repositioning
Humans
Ligands
Receptors, Adrenergic, beta-3--genetics
Syndrome
Translational Research, Biomedical
Urinary Bladder--physiology
Urinary Bladder, Overactive--drug therapy